SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

08 Feb 2022 Evaluate
The turnover for the December 2021 quarter moved up 61.50% to Rs. 2766.41 millions as compared to Rs. 1713.00 millions during the year-ago period.Net Profit witnessed a 117.80% growth almost the double from Rs. 168.79 millions to Rs. 367.63  millions  of same quarter last year.Operating profit surged to 695.47 millions from the corresponding previous quarter of 392.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 2766.41 1713.00 61.50 8028.39 6506.14 23.40 8303.16 8059.71 3.02
Other Income 130.04 86.06 51.10 319.01 187.62 70.03 339.00 112.63 200.99
PBIDT 695.47 392.99 76.97 1927.22 2084.22 -7.53 2609.07 2561.68 1.85
Interest 65.97 39.47 67.14 214.34 108.27 97.97 174.68 43.29 303.51
PBDT 629.50 353.52 78.07 1801.97 2505.44 -28.08 2963.87 2472.97 19.85
Depreciation 146.07 104.80 39.38 394.18 302.29 30.40 408.48 349.57 16.85
PBT 483.43 248.72 94.37 1407.79 2203.15 -36.10 2555.39 2123.40 20.34
TAX 115.80 79.93 44.88 352.47 625.16 -43.62 711.47 441.46 61.16
Deferred Tax 31.33 34.71 -9.74 106.50 239.84 -55.60 264.48 50.52 423.52
PAT 367.63 168.79 117.80 1055.32 1577.99 -33.12 1843.92 1681.94 9.63
Equity 86.80 81.53 6.46 86.80 81.53 6.46 81.53 81.53 0.00
PBIDTM(%) 25.14 22.94 9.58 24.01 32.03 -25.07 31.42 31.78 -1.14

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×